Visionary Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -348.20%
- Ebitda -355.32%
- Net Worth -170.87%
- Total Assets 5.35%
About Visionary Life Sciences
Visionary Life Sciences Private Limited (VLSPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 31 August 2016 (Eight years and five months 14 days old ). Its registered office is in Satara, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Yatin Kantak, Jyoti Thakkar, and Deep Thackar serve as directors at the Company.
Company Details
-
Location
Satara, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999PN2016PTC166229
-
Company No.
166229
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
31 Aug 2016
-
Date of AGM
10 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Visionary Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yatin Kantak
|
Director | 31-Aug-2016 | Current |
|
Jyoti Thakkar
|
Director | 17-Mar-2021 | Current |
|
Deep Thackar
|
Director | 25-Sep-2017 | Current |
Financial Performance of Visionary Life Sciences.
Visionary Life Sciences Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 348.2% decrease in profit. The company's net worth observed a substantial decline by a decrease of 170.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Visionary Life Sciences?
In 2018, Visionary Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Petzzworld Tech LlpYatin Kantak is a mutual person
-
Thinkstrat Global Llp
Yatin Kantak is a mutual person
-
Satara Stone Crusher Pvt Ltd
Jyoti Thakkar is a mutual person
-
Daaharsh Foods Private Limited
Deep Thackar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Visionary Life Sciences?
Unlock and access historical data on people associated with Visionary Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Visionary Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Visionary Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
